KVUE - NYSE

Kenvue Inc.

KVUE·NYSE

$16.83

-3.0%

Consumer DefensiveHousehold & Personal Products

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$32.31B

EPS0.7700

P/E Ratio21.86

Earnings Date08/06/2026

27.08B

Assets

3Y-1.0%

5Y-7.0%

10Y-7.0%

16.31B

Total Liabilities

3Y+122.0%

5Y+51.0%

10Y+51.0%

10.77B

Total Equity

11%

3Y-46.0%

5Y-41.0%

10Y-41.0%

Kenvue Inc. Funding & Solvency Profile

KVUE · NYSE

Current Assets

Cash & Cash Equivalents1.06B

Net Receivables0.00

Inventory1.67B

Other Current Assets2.97B

Total Current Assets6 B

Non-Current Assets

Property, Plant & Equipment2.21B

Goodwill & Intangible Assets18.20B

Long-Term Investments0.00

Other Non-Current Assets727.00M

Total Non-Current Assets3 B

Total Assets

27.08B

Financial Health Analysis

Current Ratio

0.96x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

1.52x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

-248000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

21% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Kenvue Inc. Balance Sheet

KVUE • NYSE

Kenvue Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	1.1B	1.1B	1.4B	1.2B	740M	618M
Cash & Short-Term Investments	1.1B	1.1B	1.4B	1.2B	740M	618M
Net Receivables	0.0	2.7B	2.6B	2.3B	2.3B	2.1B
Accounts Receivables	0.0	2.2B	2.1B	2.1B	2.1B	1.9B
Other Receivables	0.0	494M	567M	175M	257M	272M
Inventory	1.7B	1.6B	1.9B	2.2B	1.7B	1.7B
Other Current Assets	3B	205M	265M	123M	154M	162M
Total Current Assets	5.7B	5.5B	6.1B	5.9B	4.9B	4.6B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	2.2B	1.8B	2B	1.8B	1.8B	2B
Goodwill	9.5B	8.8B	9.3B	9.2B	9.8B	10.3B
Intangible Assets	8.7B	8.5B	9.6B	9.9B	10.7B	11.6B
Goodwill & Intangible Assets	18.2B	17.3B	18.9B	19B	20.5B	21.9B
Tax Assets	237M	184M	158M	147M	189M	193M
Other Non-Current Assets	727M	726M	623M	434M	475M	496M
Total Non-Current Assets	21.4B	20.1B	21.7B	21.4B	23B	24.6B
Total Assets	27.1B	25.6B	27.9B	27.3B	27.9B	29.2B
LIABILITIES
CURRENT LIABILITIES
Total Payables	2.5B	2.4B	2.7B	2.2B	2.2B	2B
Accounts Payable	2.5B	2.3B	2.5B	1.8B	1.8B	1.6B
Other Payables	0.0	156M	255M	329M	357M	393M
Accrued Expenses	0.0	1.4B	1.7B	1.5B	1.5B	5.3B
Short Term Debt	1.5B	1.6B	599M	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	36M	44M	35M	47M	0.0
Tax Payables	105M	156M	255M	329M	357M	393M
Other Current Liabilities	2B	325M	406M	272M	266M	252M
Total Current Liabilities	5.9B	5.7B	5.5B	3.9B	4B	7.5B
NON-CURRENT LIABILITIES
Long Term Debt	7.1B	6.9B	7.7B	8.9B	0.0	0.0
Deferred Tax Liabilities (Non-Current)	2.4B	2.3B	2.6B	2.5B	2.4B	1.8B
Other Non-Current Liabilities	941M	802M	754M	-8.1B	976M	1.6B
Total Non-Current Liabilities	10.4B	10.2B	11.2B	3.4B	3.5B	3.3B
Capital Lease Obligations	0.0	225M	141M	116M	129M	0.0
Total Liabilities	16.3B	15.9B	16.6B	7.3B	7.5B	10.8B
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	-242M	-7M	0.0	0.0	0.0
Common Stock	19M	19M	19M	0.0	0.0	0.0
Additional Paid-In Capital	0.0	16.1B	16.1B	0.0	0.0	0.0
Retained Earnings	-204M	-93M	429M	0.0	0.0	0.0
Accumulated Other Comprehensive Income/Loss	-5B	-6.1B	-5.4B	-5.5B	-4.5B	-3.6B
Other Total Stockholders' Equity	15.9B	0.0	0.0	25.4B	24.9B	21.9B
Total Stockholders' Equity	10.8B	9.7B	11.2B	20B	20.4B	18.4B
Total Equity	10.8B	9.7B	11.2B	20B	20.4B	18.4B
SUMMARY
Total Liabilities & Equity	27.1B	25.6B	27.9B	27.3B	27.9B	29.2B
Total Debt	8.5B	8.7B	8.4B	9B	129M	0.0
Net Debt	7.5B	7.6B	7B	7.8B	-611M	-618M
Shares Outstanding	1,916,475,112	1,916,475,112	1,916,475,112	1,916,475,112	1,916,475,112	1,916,475,112

SEC Filings

KVUE - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 22, 2026	May 21, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 15, 2026	April 10, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	April 08, 2026	December 28, 2025	2025	View Filing
10-K 10-K 2025 FY FY	February 20, 2026	December 28, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 17, 2026	February 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 12, 2026	February 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 29, 2026	January 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 16, 2026	January 16, 2026	2026	View Filing

Showing 1 to 10 of 56 filings

Related Guides

Blog Categories

Continue your KVUE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.